154 related articles for article (PubMed ID: 22558419)
1. Lysozyme resistance in Streptococcus suis is highly variable and multifactorial.
Wichgers Schreur PJ; van Weeghel C; Rebel JM; Smits MA; van Putten JP; Smith HE
PLoS One; 2012; 7(4):e36281. PubMed ID: 22558419
[TBL] [Abstract][Full Text] [Related]
2. A functional peptidoglycan hydrolase characterized from T4SS in 89K pathogenicity island of epidemic Streptococcus suis serotype 2.
Zhong Q; Zhao Y; Chen T; Yin S; Yao X; Wang J; Lu S; Tan Y; Tang J; Zheng B; Hu F; Li M
BMC Microbiol; 2014 Mar; 14():73. PubMed ID: 24655418
[TBL] [Abstract][Full Text] [Related]
3. Understanding the Structure-Function Relationship of Lysozyme Resistance in Staphylococcus aureus by Peptidoglycan O-Acetylation Using Molecular Docking, Dynamics, and Lysis Assay.
Pushkaran AC; Nataraj N; Nair N; Götz F; Biswas R; Mohan CG
J Chem Inf Model; 2015 Apr; 55(4):760-70. PubMed ID: 25774564
[TBL] [Abstract][Full Text] [Related]
4. Characterization and functional analysis of atl, a novel gene encoding autolysin in Streptococcus suis.
Ju CX; Gu HW; Lu CP
J Bacteriol; 2012 Mar; 194(6):1464-73. PubMed ID: 22228730
[TBL] [Abstract][Full Text] [Related]
5. [Identification and characterization of a novel infection-related factor (cell wall hydrolase/autolysin) of Streptococcus suis serotype 2].
Gu H; Lu C
Wei Sheng Wu Xue Bao; 2008 Jan; 48(1):68-72. PubMed ID: 18338579
[TBL] [Abstract][Full Text] [Related]
6. The VraSR regulatory system contributes to virulence in Streptococcus suis via resistance to innate immune defenses.
Chang P; Li W; Shi G; Li H; Yang X; Xia Z; Ren Y; Li Z; Chen H; Bei W
Virulence; 2018 Dec; 9(1):771-782. PubMed ID: 29471718
[TBL] [Abstract][Full Text] [Related]
7. Sialylation of Streptococcus suis serotype 2 is essential for capsule expression but is not responsible for the main capsular epitope.
Lecours MP; Fittipaldi N; Takamatsu D; Okura M; Segura M; Goyette-Desjardins G; Van Calsteren MR; Gottschalk M
Microbes Infect; 2012 Sep; 14(11):941-50. PubMed ID: 22521569
[TBL] [Abstract][Full Text] [Related]
8. Identification and characterization of the cps locus of Streptococcus suis serotype 2: the capsule protects against phagocytosis and is an important virulence factor.
Smith HE; Damman M; van der Velde J; Wagenaar F; Wisselink HJ; Stockhofe-Zurwieden N; Smits MA
Infect Immun; 1999 Apr; 67(4):1750-6. PubMed ID: 10085014
[TBL] [Abstract][Full Text] [Related]
9. Streptococcus suis serotype 2 mutants deficient in capsular expression.
Charland N; Harel J; Kobisch M; Lacasse S; Gottschalk M
Microbiology (Reading); 1998 Feb; 144 ( Pt 2)():325-332. PubMed ID: 9493370
[TBL] [Abstract][Full Text] [Related]
10. Bacillus subtilis σ(V) confers lysozyme resistance by activation of two cell wall modification pathways, peptidoglycan O-acetylation and D-alanylation of teichoic acids.
Guariglia-Oropeza V; Helmann JD
J Bacteriol; 2011 Nov; 193(22):6223-32. PubMed ID: 21926231
[TBL] [Abstract][Full Text] [Related]
11. Why are pathogenic staphylococci so lysozyme resistant? The peptidoglycan O-acetyltransferase OatA is the major determinant for lysozyme resistance of Staphylococcus aureus.
Bera A; Herbert S; Jakob A; Vollmer W; Götz F
Mol Microbiol; 2005 Feb; 55(3):778-87. PubMed ID: 15661003
[TBL] [Abstract][Full Text] [Related]
12. Mechanism of killing of pneumococci by lysozyme.
Coonrod JD; Varble R; Yoneda K
J Infect Dis; 1991 Sep; 164(3):527-32. PubMed ID: 1678400
[TBL] [Abstract][Full Text] [Related]
13. Significant contribution of the pgdA gene to the virulence of Streptococcus suis.
Fittipaldi N; Sekizaki T; Takamatsu D; de la Cruz Domínguez-Punaro M; Harel J; Bui NK; Vollmer W; Gottschalk M
Mol Microbiol; 2008 Dec; 70(5):1120-35. PubMed ID: 18990186
[TBL] [Abstract][Full Text] [Related]
14. Helicobacter pylori peptidoglycan modifications confer lysozyme resistance and contribute to survival in the host.
Wang G; Lo LF; Forsberg LS; Maier RJ
mBio; 2012 Dec; 3(6):e00409-12. PubMed ID: 23221800
[TBL] [Abstract][Full Text] [Related]
15. Effect of the glycosyltransferases on the capsular polysaccharide synthesis of Streptococcus suis serotype 2.
Zhang Y; Ding D; Liu M; Yang X; Zong B; Wang X; Chen H; Bei W; Tan C
Microbiol Res; 2016 Apr; 185():45-54. PubMed ID: 26946377
[TBL] [Abstract][Full Text] [Related]
16. Role of the Streptococcus suis serotype 2 capsular polysaccharide in the interactions with dendritic cells is strain-dependent but remains critical for virulence.
Auger JP; Dolbec D; Roy D; Segura M; Gottschalk M
PLoS One; 2018; 13(7):e0200453. PubMed ID: 30001363
[TBL] [Abstract][Full Text] [Related]
17. Resistance to mucosal lysozyme compensates for the fitness deficit of peptidoglycan modifications by Streptococcus pneumoniae.
Davis KM; Akinbi HT; Standish AJ; Weiser JN
PLoS Pathog; 2008 Dec; 4(12):e1000241. PubMed ID: 19079576
[TBL] [Abstract][Full Text] [Related]
18. Critical role for Streptococcus suis cell wall modifications and suilysin in resistance to complement-dependent killing by dendritic cells.
Lecours MP; Gottschalk M; Houde M; Lemire P; Fittipaldi N; Segura M
J Infect Dis; 2011 Sep; 204(6):919-29. PubMed ID: 21849289
[TBL] [Abstract][Full Text] [Related]
19. Streptococcus suis serotype 2 strains can induce the formation of neutrophil extracellular traps and evade trapping.
Zhao J; Pan S; Lin L; Fu L; Yang C; Xu Z; Wei Y; Jin M; Zhang A
FEMS Microbiol Lett; 2015 Mar; 362(6):. PubMed ID: 25673283
[TBL] [Abstract][Full Text] [Related]
20. Rapid PCR test for Streptococcus suis serotype 7.
Smith HE; van Bruijnsvoort L; Buijs H; Wisselink HJ; Smits MA
FEMS Microbiol Lett; 1999 Sep; 178(2):265-70. PubMed ID: 10499276
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
